A clinical trial assessing if the current transfusion and ICT protocols may support a normal growth progression and sexual development in patients (pts) with thalassemia major
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Deferasirox (Primary) ; Deferoxamine (Primary)
- Indications Thalassaemia
- Focus Therapeutic Use
- 08 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association